DTx Equals

Join us on the latest episode! Our Guest: Andy Molnar, CEO of the Digital Therapeutics Alliance.What you'll get out of this episode:Andy Molnar’s transition from the pharmaceutical industry to DTX.The current challenges facing digital therapeutics.Predictions for the future of digital health and patient-centric care.To learn more about Digital Therapeutics Alliance: https://dtxal

Join us on the latest episode! Our Guest: Anish Shindore, Founder & Managing Partner of GSD HealthWhat you'll get out of this episode:- The importance of merging science and tech in healthcare- The need for DTX to deliver real patient outcomes- Overcoming barriers to DTX adoption through education- The stark differences in U.S. and European startup funding- How investors are sh

Join us on the latest episode! Our Guest: Mark Wuttke CEO of DopavisionWhat you'll get out of this episode:Explore DopaVision's digital approach to controlling Myopia in young populations.Discussion on digital therapeutics enhancing healthcare delivery.Transition from traditional pharmaceuticals to digital therapeutics.Mark's journey from Novartis to DopaVision and the potential of

Join us on the latest episode! Our Guest: Tracy Dennis-Tiwary, Co-Founder and CSO at Arcade TherapeuticsWhat you'll get out of this episode:Learn about the fusion of neuroscience, game design, and digital therapeutics.Explore Arcade Therapeutics' mission to transform mental health solutions through game-based digital approaches.Discover the journey and motivation behind venturing i

Join us on the latest episode! Our Guest: Soňa Sikorová, CEO and Co-Founder at MindpaxWhat you'll get out of this episode:Introduction to Digital Therapeutics (#DTX) in the field of mental health.Insights from Sona Nevicka-Sikorova, CEO of #MindPax.Discussion on the future trajectories of DTX.Challenges and innovations in the DTX domain.Exploring MindPax's unique approach to pati

Join us on the latest episode! Our Guest: Jordan Glenn, Chief Science Officer at NeurotrackWhat you'll get out of this episode:- Digital Therapeutics transforming healthcare, especially in cognitive health assessments- Jordan Glenn shifted to cognitive health inspired by a family member's Alzheimer's battle- Neurotrack focuses on quick, accurate digital cognitive assessments- Imple

Welcome to DTx Equals, the show where thought-leaders in digital therapeutics put a stake in the ground about what makes DTx, DTx.Our Guest Today: Simon Thomas, President at FreespiraWhat you'll get out of this episode:What's a formative event in your life or career that influenced your path in DTX?Observations on the ways that FDA is now working with companies now to demonstrate t

Welcome to DTx Equals, the show where thought-leaders in digital therapeutics put a stake in the ground about what makes DTx, DTx.Our Guest Today: Amber Trivedi, COO at Blue Note TherapeuticsWhat you'll get out of this episode:What is a formative event in your life or career that influenced your path into DTx?DTx equals what? What is the most defining issue of DTx today? How much o

Welcome to DTx Equals, the show where thought-leaders in digital therapeutics put a stake in the ground about what makes DTx, DTx.Our Guest Today: Jorge Palacios, Chief Science Officer at Bright TherapeuticsWhat you'll get out of this episode:What’s a formative event in Palacios' career that influenced his path in DTx, and how saying "yes" shaped his path of opportunityWhat about

Welcome to DTx Equals, the show where thought-leaders in digital therapeutics put a stake in the ground about what makes DTx, DTx.Our Guest Today: Jen Goldsack, Chief Executive Officer at DiMeWhat you'll get out of this episode:What’s a formative event in Goldsack's life or career that influenced her path in DTx"DTx equals" what? What's the most defining issue in DTx today? In he